Menu

Researchers Mine Centipede Toxins for Analgesics

Venomous centipedes may harbor a clue to the creation of a successful pain-killing compound for humans.

Jan 1, 2018
Catherine Offord

ELVIND UNDHEIM

Centipede venom has a long history as a painkiller—toxins from the Chinese red-headed centipede (Scolopendra subspinipes mutilans) have been used in Chinese medicine for hundreds of years. But the leggy creature’s arsenal has only recently gained attention as inspiration for modern analgesics. “There’s on the order of 3,000 venomous centipedes,” says Glenn King, a biochemist at the University of Queensland, Australia. “Yet they’re massively underexplored in terms of what’s in the venom.”

In 2013, King and colleagues reported that one centipede-made peptide, Ssm6a, selectively inhibits NaV1.7—a voltage-gated sodium channel implicated in pain sensing in mammals, including humans (PNAS, 110:17534-39). In rodent models, Ssm6a was more potent than morphine, though the finding has yet to be reproduced. Last year, a Chinese team showed that another centipede peptide, potassium channel blocker SsmTX-I, has analgesic properties in mice (J Ppt Sci, 23:384-91, 2017).

“These venoms are full of ion-channel modulators,” says King. From a pain-killing perspective, “some of those molecules may turn out to be more or less useful therapeutically—we just don’t know yet.”

Read about other animal groups researchers are exploring for pain-killing leads in the full feature story, “Animal Analgesics.”

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.